<DOC>
	<DOCNO>NCT02413970</DOCNO>
	<brief_summary>The purpose study obtain additional long-term safety efficacy data use Inspire therapy .</brief_summary>
	<brief_title>Inspire® Post-Approval Study / Protocol Number 2014-001</brief_title>
	<detailed_description>This multi-center , prospective , single-arm study conduct common protocol . Each subject serve control . Each subject follow 5 year date implant . Potential study subject consider study participation consent pre-implant screening implant qualification process complete . This include in-lab PSG , surgical consultation , drug-induced sleep endoscopy procedure . This study collect pre-operative baseline data include , verification ineffective CPAP treatment , PSG information , medical history subject quality life measure . Intra- post- operative procedure data collect . Post-implant , procedure- device-related adverse event , QoL questionnaires , Functional Tongue Exam , therapy usage device adjustment data collect . In-lab PSG sleep study data collect 2-month 1 &amp; 3 year follow-up visit , home sleep test conduct data collect 6-month 2 , 4 , &amp; 5 year follow-up visit . The subject population consist otherwise healthy men woman least 22 year old : 1 ) Provided write informed consent participate , 2 ) Indicated willingness comply study requirement specify follow-up duration , 3 ) Met inclusion exclusion criterion protocol . Up 127 subject implant minimum 10 maximum 20 qualified site United States .</detailed_description>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<criteria>1 . Likely suffer moderatetosevere OSA base history physical establish diagnosis OSA ( 20≤AHI≤65 ) base prior inlab Polysomnography 2 . Documentation subject effectively treat CPAP therapy . ( Examples include noncompliance , discomfort , undesirable side effect , symptom persist despite use ) . Subjects prescribed , refuse try CPAP would consider intolerant . 3 . Age 22 4 . Willing capable stimulation hardware permanently implant , use patient remote activate stimulation 5 . Willing capable return followup visit conduct sleep study home , include evaluation procedure fill questionnaire 6 . Willing capable providing inform consent Contraindications : 1 . Central + mixed apnea &gt; 25 % total apneahypopnea index ( AHI ) 2 . Any anatomical finding would compromise performance upper airway stimulation , presence complete concentric collapse soft palate 3 . Any condition procedure compromise neurological control upper airway 4 . Patients unable necessary assistance operate patient remote 5 . Patients pregnant plan become pregnant 6 . Patients require magnetic resonance imaging ( MRI ) 7 . Patients implantable device may susceptible unintended interaction Inspire system . Additional exclusion study purpose : 1 . Body Mass Index ( BMI ) &gt; 32 2 . Any chronic medical illness condition contraindicate surgical procedure general anesthesia , judge clinical study Investigator 3 . Has terminal illness life expectancy &lt; 12 month 4 . Active psychiatric disease ( psychotic illness , major depression , acute anxiety attack ) prevents subject compliance requirement investigational study test 5 . Any reason investigator deems subject unfit participation study</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>OSA</keyword>
	<keyword>Neurostimulation</keyword>
	<keyword>Hypoglossal nerve</keyword>
	<keyword>Tongue</keyword>
	<keyword>Upper airway stimulation</keyword>
	<keyword>Surgery</keyword>
</DOC>